导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.15% | 584/1050 |
| 近一周 | -4.12% | 989/1104 |
| 近一月 | -8.75% | 973/1102 |
| 近一季 | -12.66% | 771/1092 |
| 近半年 | -4.18% | 572/1070 |
| 近一年 | 4.07% | 489/1018 |
| 近两年 | 96.81% | 203/926 |
| 近三年 | 68.12% | 159/834 |
| 成立以来 | 313.36% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.24% 467/1070 |
10.15% 539/1101 |
- - |
- - |
| 2025 | 58.91% 122/1065 |
5.78% 355/1014 |
5.53% 268/1038 |
41.00% 178/1050 |
0.96% 405/1065 |
| 2024 | 14.98% 174/1011 |
0.16% 299/960 |
0.18% 295/983 |
16.13% 170/991 |
-1.32% 402/1011 |
| 2023 | -16.10% 570/952 |
7.28% 206/880 |
-2.51% 338/895 |
-11.92% 677/915 |
-8.92% 807/952 |
| 2022 | -24.50% 478/867 |
-17.13% 367/773 |
11.11% 221/806 |
-18.27% 719/845 |
0.33% 432/867 |
| 2021 | 17.98% 161/740 |
13.65% 4/580 |
1.30% 526/659 |
-4.13% 316/704 |
6.90% 150/740 |
| 2020 | 41.95% 290/554 |
-5.25% 298/419 |
19.62% 290/466 |
19.72% 58/517 |
4.62% 444/554 |
| 2019 | 47.99% 166/410 |
31.02% 315/1149 |
-1.28% 466/1231 |
3.17% 246/390 |
10.90% 138/410 |
| 2018 | -44.71% 282/349 |
- - |
- - |
- - |
-16.31% 929/1080 |
| 2017 | 41.13% 13/285 |
- - |
- - |
- - |
- - |
| 2016 | 2.81% 23/205 |
- - |
- - |
- - |
- - |
| 2015 | 36.98% 42/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 摩根核心成长股票A VS. 东吴新产业精选股票A(580008) |